Details of issuance or disposal
Exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price and suspension of exercise)
Shares delivered during the month: 44,500 shares (44,500 new shares and 0 transferred treasury shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Shares delivered during the month: 44,500 / shares outstanding at the end of the month preceding the applicable month: 3,297,228, approximately 1.35%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 18th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price and suspension of exercise) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 44,500 shares (44,500 new shares and 0 transferred treasury shares) |
| Intended allottee | EVO FUND (issued on 4 December 2025) |
| Dilution Rate | Shares delivered during the month: 44,500 / shares outstanding at the end of the month preceding the applicable month: 3,297,228, approximately 1.35% |
| Total number of issued shares | 3,297,228 shares (as of the end of the month preceding the applicable month, including 3,616 treasury shares) → Not disclosed |
| Exercise price | Exercise prices during the month: ¥387–¥415. Lower limit under the exercise-price adjustment provision: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 10,000 rights; exercised during the month: 445 rights; unexercised at the end of the month preceding the applicable month: 6,530 rights; unexercised at month-end: 6,085 rights |
| Procedures under the Corporate Code of Conduct | The status of compliance with the exercise restrictions under Article 434 of the Listing Regulations is disclosed. |
| Most recent equity financing | Timing 4 December 2025 / Type Issuance of Series 18 Stock Acquisition Rights / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report monthly exercise activity. The document does not state the reason for the exercises or the use of proceeds.